External Validation of Delirium Prediction Models for Intensive Care Patients
1 other identifier
observational
660
1 country
1
Brief Summary
Delirium is frequently observed among critically ill patients and is associated with detrimental outcomes. Currently, no evidence-based prevention or treatment exists for delirium, and especially, the inability to identify effective preventive measures of delirium has increased the focus on identifying patients with a high risk of delirium through prediction models. Two prediction models have been developed to estimate the risk of delirium in ICU patients: the prediction model for delirium (PRE-DELIRIC) and the early prediction model for delirium (E-PRE-DELIRIC). These robust and well-calibrated prediction models have the potential of assisting in identifying patients with the highest risk for delirium and thereby to focusing preventive strategies on the most vulnerable group. However further validation is needed in a Danish population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 6, 2021
CompletedFirst Posted
Study publicly available on registry
October 19, 2021
CompletedStudy Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedApril 8, 2025
January 1, 2023
1.6 years
October 6, 2021
April 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
AUROC for PRE-DELIRIC
Area Under the Receiver Operating Characteristics (AUROC) for PRE-DELIRIC
Duration of the study, november 2021 to september 2022
AUROC for E-PRE-DELIRIC
Area Under the Receiver Operating Characteristics (AUROC) for E-PRE-DELIRIC
Based on 14 days of ICU admission
Secondary Outcomes (4)
30-days mortality
30 days efter ICU admission
Time on ventilator
14 days after ICU admission
ICU length of stay
30 days after ICU admission
Hospital length of stay
30 days after ICU admission
Study Arms (1)
Adult patients admitted to Intensive Care Unit (ICU)
Eligible patients are scored by E-PRE-DELIRIC at admission and PRE-DELIRIC 24 hours after admission.
Interventions
The prediction scores are validated by the CAM-ICU scores up to 14 days after ICU admission.
Eligibility Criteria
All adult patients admitted to participating ICUs in the Zealand Region between November 2021 and July 2022.
You may qualify if:
- Acute admission to an ICU AND
- Age \> 18 of years
You may not qualify if:
- Total admittance to the ICU less than 24 hours
- Delirium assessment nonapplicable (hearing or visual disabilities, language barriers, or mentally incompetent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zealand University Hospital, Department of Anaesthesiology
Køge, Zealand Region of Denmark, 4600, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neeliya Anton Joseph, BSc Medicine
Department of Anaesthesiology, Zealand University Hospital, Køge, Denmark
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of ICU
Study Record Dates
First Submitted
October 6, 2021
First Posted
October 19, 2021
Study Start
January 1, 2022
Primary Completion
July 31, 2023
Study Completion
September 30, 2023
Last Updated
April 8, 2025
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- After the termination and publication of the study
- Access Criteria
- Reasonable request by researcher based on study protocol.
Individual anonymised participant data will be made available to researchers upon reasonable request after termination and publication of the study.